Molecular Insight Pharmaceuticals
Cambridge
About Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification and targeting of disease at the molecular level to improve patient healthcare by addressing significant unmet medical needs. They are focused on discovering, developing and commercializing innovative and targeted radiotherapeutics and molecular imaging pharmaceuticals with initial applications in the areas of oncology and cardiology.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Ticker: nasdaq:MIPI
- Website: molecularinsight.com
Social Profiles
Canonical: https://fsome.com/organization/molecular-insight-pharmaceuticals-2261625 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.